Product Images Glycopyrrolate

This is a description of a medication called Glycopyrrolate Injection, USP. It comes in single-dose vials with 0.2 mg/mL solution and should not be used for newborns. The medication requires intravenous or intramuscular administration and contains Benzyl Alcohol. Additional details include NDC code, dosage and prescription reminder. Note: The text contains several errors, typos, and irrelevant characters.*

This is a description of Glycopyrrolate, a drug that comes in a single-dose vial for intramuscular or intravenous use only. It is manufactured by Alembic Pharmaceuticals in India and contains benzyl alcohol. The product details include the NDC code, lot, and expiration date. The M.L.No is also provided.*

This is a description for a medication with the NDC code 62332-629-10. The medication is Glycopyrrolate Injection, USP and comes in a 20 mL multi-dose vial with a concentration of 4 mg/20 mL or 0.2 mg/mL. The medication is not for use in newborns and contains benzyl alcohol. It is for intramuscular or intravenous administration and requires a prescription. The lot number for this medication is 46C 123485 and it has a GTIN of 00862332629107.*

This is a description of the medication Glycopyrrolate Injection, USP which comes in a 20 mL multiple-dose vial. It contains Water for Injection, USP and Benzyl Alcohol, NF (preservative) at 0.9%. The pH of the medication is adjusted with hydrochloric acid and/or sodium hydroxide. The usual dosage should be referred from the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) and not for use in Newborns. The medication is for intramuscular or intravenous administration only. The medication is manufactured by Alembic Pharmaceuticals, Inc. and is made in India. The lot number is mentioned in the description along with the expiry date.*

Glycopyrrolate Injection, USP is a medication that comes in a pack of 25 single-dose vials. Each vial contains 0.4 mg/2 mL (0.2 mg/mL) of the medicine, which can be given through intravenous or intramuscular injection. However, it is not suitable for newborns and contains benzyl alcohol. The medication comes with a package insert with information on the usual dosage. It should be stored between 20°C to 25°C and unused portions should be discarded. pH can be adjusted with hydrochloric acid and/or sodium hydroxide. However, some text is not available due to errors.*

This is a description for Glycopyrrolate, an injection solution used for medical purposes. Each vial contains 0.4 mg/2 mL of Glycopyrrolate, which has been manufactured in India by Alembic Pharmaceuticals, Inc. The solution is contained in a single-dose vial and contains benzyl alcohol, making it only available for prescription use. The NDC code for the product is 62332-627-02, and the batch number is 20031727, which was produced in January 2021. The M.L. code present on the vial is G/28/1704.*

This is a description of a medication packaged in 25 multiple-dose vials, each vial containing 5 mL solution of Glycopyrrolate Injection, USP with a concentration of 1 mg per 5 mL (0.2 mg/mL) intended for intramuscular or intravenous administration. The solution contains benzyl alcohol and should be stored at a temperature range of 20°C to 25°C (68°F to 77°F). The proper dosage of the medication information can be found in the package insert. This medication is not recommended for use in newborns.*

This is a description of a medication, "Glycopyrrolate Injection, USP" which is administered through intramuscular or intravenous injection. It contains Benzyl alcohol as a preservative and is not recommended for use in newborns. The medication is diluted in Water for Injection, USP and the pH is adjusted with hydrochloric acid and/or sodium hydroxide. The usual dosage instructions are provided in the package insert. It is stored at controlled room temperature between 20°C to 25°C (68°F to 77°F) and the medication is manufactured by Alembic Pharmaceuticals, Inc. in India. The product is only available through a prescription.*